Sanara MedTech Inc. (SMTI)
| Bid | 34.5 |
| Market Cap | 310.27M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.99 |
| PE Ratio (ttm) | -35.85 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 37 |
| Volume | 10,213 |
| Avg. Volume (20D) | 27,632 |
| Open | 35.03 |
| Previous Close | 35.31 |
| Day's Range | 35.05 - 35.68 |
| 52-Week Range | 26.00 - 39.98 |
| Beta | undefined |
About SMTI
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako's Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate matur...
Analyst Forecast
According to 2 analyst ratings, the average rating for SMTI stock is "Buy." The 12-month stock price forecast is $47, which is an increase of 32.41% from the latest price.
Next Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago · seekingalpha.com
Sanara MedTech: A Promising Growth Story At An Attractive ValuationShares have risen nearly 15% since the company posted preliminary Q4 results, which showed revenue up by 45-48% year over year. While growth was boosted by one-off demand for its BIASURGE product, und...